These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Clin Transplant; 2006 May; 20(6):677-83. PubMed ID: 17100715 [Abstract] [Full Text] [Related]
5. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM, Liaw YF. Antivir Ther; 2006 May; 11(8):985-94. PubMed ID: 17302368 [Abstract] [Full Text] [Related]
6. The utility of therapeutic drug monitoring for ribavirin in patients with chronic hepatitis C--a critical review. Chan AH, Partovi N, Ensom MH. Ann Pharmacother; 2009 Dec; 43(12):2044-63. PubMed ID: 19920162 [Abstract] [Full Text] [Related]
9. Re: Khalili et al.--chronic Hepatitis C treatment in interferon nonresponders. Glaser D. Am J Gastroenterol; 2000 Nov; 95(11):3315-6. PubMed ID: 11095370 [No Abstract] [Full Text] [Related]
10. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination]. Niederau C. MMW Fortschr Med; 2008 Mar 27; 150(13):26. PubMed ID: 18522352 [No Abstract] [Full Text] [Related]
11. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C. Honda T, Katano Y, Urano F, Murayama M, Hayashi K, Ishigami M, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H. J Gastroenterol Hepatol; 2007 Jul 27; 22(7):989-95. PubMed ID: 17608843 [Abstract] [Full Text] [Related]
12. [Treatment of chronic hepatitis C. Combined treatment in naive patients]. Forns Bernhardt X. Gastroenterol Hepatol; 2000 Feb 27; 23 Suppl 1():43-6. PubMed ID: 11968343 [No Abstract] [Full Text] [Related]
13. Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin. Boo I, Fischer AE, Johnson D, Chin R, Giourouki M, Bharadwaj M, Bowden S, Torresi J, Drummer H. J Clin Virol; 2007 Aug 27; 39(4):288-94. PubMed ID: 17569577 [Abstract] [Full Text] [Related]
14. Novel approaches for therapy of chronic hepatitis C. Stauber RE, Stadlbauer V. J Clin Virol; 2006 Jun 27; 36(2):87-94. PubMed ID: 16546442 [Abstract] [Full Text] [Related]
15. Use of incomplete post-treatment data in the analysis of viral eradication studies. Cheng DM, Lagakos SW. Stat Med; 2003 Dec 15; 22(23):3611-28. PubMed ID: 14652864 [Abstract] [Full Text] [Related]
16. Clinical use of interferon in hepatitis B and C. Schalm SW. Verh K Acad Geneeskd Belg; 2009 Dec 15; 71(1-2):87-99. PubMed ID: 19739400 [Abstract] [Full Text] [Related]
17. Review article: the treatment of hepatitis C virus recurrence after liver transplantation. Arjal RR, Burton JR, Villamil F, Rosen HR. Aliment Pharmacol Ther; 2007 Jul 15; 26(2):127-40. PubMed ID: 17593060 [Abstract] [Full Text] [Related]
18. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals. Mauss S. J HIV Ther; 2007 Mar 15; 12(1):11-7. PubMed ID: 17589391 [Abstract] [Full Text] [Related]
19. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin. Fujita N, Kaito M, Kai M, Sugimoto R, Tanaka H, Horiike S, Konishi M, Iwasa M, Watanabe S, Adachi Y. J Viral Hepat; 2006 Jul 15; 13(7):441-8. PubMed ID: 16792537 [Abstract] [Full Text] [Related]